Loratadine And Pseudoephedrine Sulfate
Product Images NDC 68016-724

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Loratadine And Pseudoephedrine Sulfate (NDC 68016-724). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chain Drug Consortium, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (10 Tablet Blister Pack Carton)

The packaging label for Loratadine and Pseudoephedrine Sulfate Extended-Release Tablets by Chain Drug Consortium, LLC. The Premier Value branded box includes the active ingredients Loratadine USP 10 mg and Pseudoephedrine Sulfate USP 240 mg as nasal decongestant. It lists relief for indoor and outdoor allergies, nasal and sinus congestion due to colds or allergies, and symptoms like sneezing, runny nose, itchy watery eyes, and itchy throat or nose. The package contains 10 extended-release tablets. The label also states comparison to Claritin-D 24 Hour and includes barcodes and trademark information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.